Previous close | 5.00 |
Open | 5.77 |
Bid | 4.27 x 200 |
Ask | 5.98 x 300 |
Day's range | 5.18 - 6.01 |
52-week range | 3.92 - 27.70 |
Volume | |
Avg. volume | 879,940 |
Market cap | 368.948M |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
On May 13, 2024, Richard Mott, a Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 120,000 shares of the company, as reported in a recent SEC Filing.